In patients with primary tumors of breast cancer, hydralazine (a DNA demethylation agent) and magnesium valproate up- and downregulate 1091 and 89 genes, respectively, by at least 3-fold; ABCB5 was only downregulated [35]. The gene discussed is ABCB5; the disease is breast cancer.